Beauty Competitors

Stocks . USA . 
Stock . Beauty Health Co
SKIN Stock  USD 1.41  0.09  6.00%   
Beauty Health competes with Procter Gamble, Morningstar Unconstrained, T Rowe, First Physicians, and SEI Investments; as well as few others. The company conducts business under Personal Care Products sector and is part of Consumer Staples industry. Analyzing Beauty Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Beauty Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Beauty Health Correlation with its peers.

Beauty Health vs Virtus Dfa Correlation

Very weak diversification

The correlation between Beauty Health Co and VTARX is 0.56 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Beauty Health Co and VTARX in the same portfolio, assuming nothing else is changed.

Moving together with Beauty Stock

  0.77EL Estee Lauder Companies Earnings Call TomorrowPairCorr

Moving against Beauty Stock

  0.4FSTF First State FinancialPairCorr
  0.33COTY Coty Inc Earnings Call This WeekPairCorr
As of the 4th of February 2026, Return On Tangible Assets is likely to drop to -0.05. In addition to that, Return On Capital Employed is likely to drop to -0.13. At this time, Beauty Health's Net Tangible Assets are very stable compared to the past year. As of the 4th of February 2026, Other Assets is likely to grow to about 18.1 M, while Total Assets are likely to drop about 785.7 M.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.071.415.34
Details
Intrinsic
Valuation
LowRealHigh
0.061.195.12
Details
Naive
Forecast
LowNextHigh
0.031.355.28
Details
9 Analysts
Consensus
LowTargetHigh
1.781.962.17
Details

Beauty Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Beauty Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Beauty and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Beauty Health does not affect the price movement of the other competitor.

High positive correlations

RRTLX
+ 0.97
MSTSX
VTARX
+ 0.95
RRTLX
VTARX
+ 0.94
MSTSX
SEIC
+ 0.88
RRTLX
SEIC
+ 0.86
MSTSX
VTARX
+ 0.84
SEIC
  

High negative correlations

GVPIX
- 0.73
GSFP
GVPIX
- 0.69
RRTLX
VTARX
- 0.67
GVPIX
GVPIX
- 0.67
MSTSX
GVPIX
- 0.66
SEIC
TTNDY
- 0.54
GVPIX

Risk-Adjusted Indicators

There is a big difference between Beauty Stock performing well and Beauty Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Beauty Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
PG  0.94  0.07  0.03  1.25  1.07 
(1.05)
 1.84 
(1.55)
 5.66 
MSTSX  0.65  0.15  0.16  0.61  0.44 
(0.81)
 0.93 
(1.09)
 12.28 
RRTLX  0.26  0.04  0.04  0.17  0.15 
(0.33)
 0.57 
(0.49)
 3.30 
GSFP  0.55  0.18  0.22  1.77  0.33 
(0.68)
 1.27 
(1.10)
 3.10 
FPCG  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
GSFI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
SEIC  0.99  0.02  0.02  0.06  1.40 
(1.01)
 2.10 
(1.71)
 7.41 
GVPIX  0.47 (0.09) 0.00 (0.46) 0.00 
 0.00 
 0.76 
(1.23)
 2.68 
TTNDY  1.48  0.09  0.04  0.18  1.92 
(1.41)
 3.23 
(2.45)
 7.25 
VTARX  0.67  0.18  0.28  0.36  0.00 
(0.90)
 0.86 
(0.83)
 17.94 

Cross Equities Net Income Analysis

Compare Beauty Health and related stocks such as Procter Gamble, Morningstar Unconstrained, and T Rowe Price Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AGraham Number
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
20102011201220132014201520162017201820192020202120222023202420252026
PG709 M10.8 B11.3 B11.6 B7 B10.5 B15.3 B9.8 B3.9 B13 B14.3 B14.7 B14.7 B14.9 B16 B18.4 B19.3 B
SEIC3.8 M205 M206.8 M288.1 M318.7 M331.7 M333.8 M404.4 M505.9 M501.4 M447.3 M546.6 M475.5 M462.3 M581.2 M715.3 M751.1 M

Beauty Health and related stocks such as Procter Gamble, Morningstar Unconstrained, and T Rowe Price Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Beauty Health financial statement analysis. It represents the amount of money remaining after all of Beauty Health Co operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Beauty Health Competitive Analysis

The better you understand Beauty Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Beauty Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Beauty Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SKIN PG MSTSX RRTLX GSFP FPCG GSFI SEIC GVPIX TTNDY
 6.00 
 1.41 
Beauty
 1.39 
 155.32 
Procter
 0.18 
 11.28 
Morningstar
 0.16 
 12.89 
RRTLX
 0.00 
 33.78 
Goldman
 0.00 
 1,025 
First
 0.00 
 0.0001 
Green
 5.14 
 84.13 
SEI
 0.22 
 31.87 
GVPIX
 2.13 
 69.17 
Techtronic
Market Volatility
(90 Days Market Risk)
Dangerous
Very steady
Not too volatile
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Weakest
Fair
Good
Good
Weakest
Weakest
Weakest
Weak
Weakest
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
High
Low
Low
Low
Low
Low
Risky
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Under Valued
Over Valued
Under Valued
Fairly Valued
Over Valued
Fairly Valued
Fairly Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Hold
Strong Buy
Not Available
Not Available
Not Available
Not Available
Not Available
Buy
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Hold
Strong Buy
Strong Sell
Not Rated
Hold
Strong Sell
Hold
Cautious Hold
Strong Buy
Current Ratio
11.68
0.62
N/A
N/A
N/A
5.06
N/A
4.43
N/A
1.41
Net Asset
685.68 M
125.23 B
116.1 M
1.46 B
153.54 M
37.35 M
1.24 M
2.68 B
10.6 M
13.01 B
EBITDA
10.34 M
23.92 B
N/A
N/A
N/A
9.7 M
(3.68 M)
859.28 M
N/A
1.65 B
Operating Margin
-0.0883
0.26
N/A
N/A
N/A
0.42
N/A
0.27
N/A
0.0895
Five Year Return
N/A
2.67
9.05
0.0406
N/A
N/A
N/A
1.18
-12.91
1.42
One Year Return
N/A
N/A
17.14
0.067
8.2
N/A
N/A
N/A
1.35
N/A
Beta
1.15
0.38
N/A
N/A
1.25
-8.37
1.62
0.95
N/A
1.44
Number Of Employees
769
109 K
1
1
N/A
3
6
5.07 K
1
47.57 K
Three Year Return
N/A
N/A
12.9
0.0491
5.9
N/A
N/A
N/A
-6.58
N/A
Cash Flow From Operations
16.13 M
17.82 B
N/A
N/A
N/A
3.25 M
(1.92 M)
622.34 M
N/A
(100.94 M)
Total Debt
568.16 M
35.46 B
N/A
N/A
N/A
5.69 M
856.4 K
32.13 M
N/A
1.03 B
Bond Positions Weight
N/A
N/A
22.72
14.43
N/A
N/A
N/A
N/A
N/A
N/A
Holdings Turnover
N/A
N/A
269.0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.0292
0.11
N/A
N/A
N/A
0.16
0.0254
0.13
N/A
0.0601
Current Liabilities
N/A
30.77 B
N/A
N/A
N/A
3.83 M
N/A
224.48 M
N/A
2.24 B
Debt To Equity
2.91
0.74
N/A
N/A
N/A
0.34
3.01
0.015
N/A
0.78
Short Ratio
42.09
1.81
N/A
N/A
N/A
N/A
N/A
2.45
N/A
N/A
Shares Owned By Institutions
89.03
70.61
N/A
N/A
N/A
N/A
N/A
74.45
N/A
0.09
Market Capitalization
191.25 M
363.52 B
50.36 M
N/A
N/A
10.07 M
864.68 K
10.86 B
N/A
25.26 B
Price To Earning
43.17
25.21
N/A
18.25
N/A
0.09
N/A
19.7
2.7
25.69
Price To Sales
0.63
4.26
N/A
1.57
N/A
0.44
N/A
4.73
N/A
1.57
Net Income
(29.1 M)
16.07 B
N/A
N/A
N/A
5.77 M
(3.81 M)
581.19 M
N/A
1.1 B
Shares Owned By Insiders
11.65
0.071
N/A
N/A
N/A
N/A
0.85
16.79
N/A
N/A
Revenue
334.29 M
84.28 B
N/A
N/A
N/A
19.39 M
N/A
2.3 B
N/A
13.2 B
Year To Date Return
N/A
N/A
2.37
-0.0211
N/A
N/A
N/A
N/A
0.82
N/A
Working Capital
408.97 M
(10.67 B)
N/A
N/A
N/A
15.53 M
N/A
1.17 B
N/A
978 M
Profit Margin
-0.0389
0.19
N/A
N/A
N/A
0.39
N/A
0.31
N/A
0.0833
Current Valuation
352.11 M
382.59 B
N/A
N/A
N/A
4.19 M
1.68 M
10.42 B
N/A
25.37 B
Price To Book
2.93
6.81
N/A
2.13
N/A
0.0516
2.9
4.43
N/A
4.49
Retained Earnings
(507.96 M)
129.97 B
N/A
N/A
N/A
(76.95 M)
N/A
758 M
N/A
1.73 B
Current Asset
N/A
33.78 B
N/A
N/A
N/A
19.36 M
N/A
1 B
N/A
3.21 B
Cash Position Weight
N/A
N/A
14.28
7.22
N/A
N/A
N/A
N/A
100.0
N/A
Equity Positions Weight
N/A
N/A
61.63
38.52
100.0
N/A
N/A
N/A
N/A
N/A
Shares Outstanding
127.5 M
2.34 B
N/A
N/A
N/A
9.83 K
4.32 B
122.23 M
N/A
366.94 M
Annual Yield
N/A
0.0272
0.0223
0.0288
N/A
10.7
N/A
0.0114
0.0155
0.0184
Return On Equity
-0.19
0.32
N/A
N/A
N/A
0.69
-37.22
0.29
N/A
0.25
Z Score
N/A
N/A
N/A
N/A
N/A
-2.2
-6.0
N/A
N/A
15.4
Number Of Shares Shorted
16.68 M
18.96 M
N/A
N/A
N/A
N/A
N/A
1.49 M
N/A
N/A
Book Value Per Share
0.52
22.49
N/A
N/A
N/A
415.98
N/A
20.03
N/A
13.76
Minimum Initial Investment
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
15 K
N/A
Total Asset
685.68 M
125.23 B
215.11 M
1.03 B
153.54 M
37.35 M
1.24 M
2.68 B
9.62 M
13.01 B
Target Price
1.96
167.45
N/A
N/A
N/A
N/A
N/A
101.67
N/A
112.4
Last Dividend Paid
N/A
4.18
N/A
0.14
N/A
N/A
N/A
1.01
N/A
0.25
Price To Earnings To Growth
0.95
4.66
N/A
N/A
N/A
N/A
N/A
1.47
N/A
N/A
Earnings Per Share
-0.16
6.76
N/A
N/A
N/A
10991.96
0.01
5.63
N/A
3.14
Ten Year Return
N/A
N/A
N/A
5.76
N/A
N/A
N/A
N/A
9.16
N/A
Cash And Equivalents
684.21 M
9.56 B
N/A
N/A
N/A
1.89 M
25
791.44 M
N/A
1.67 B
Cash Per Share
4.78
2.83
N/A
N/A
N/A
158.09
N/A
5.87
N/A
4.56
Gross Profit
195.67 M
43.64 B
N/A
N/A
N/A
19.39 M
N/A
1.8 B
N/A
5.12 B
Day Typical Price
1.44
154.61
11.28
12.89
33.78
1025.0
1.0E-4
85.27
31.87
68.97
Accumulation Distribution
59461.75
0.0137
N/A
N/A
N/A
N/A
N/A
65953.22
N/A
1331.26
Market Facilitation Index
N/A
2.13
N/A
N/A
N/A
N/A
N/A
0.0
N/A
0.0
Daily Balance Of Power
(0.75)
1.0
9.2 T
9.2 T
0.0
0.0
0.0
(0.79)
9.2 T
2.285714
Period Momentum Indicator
(0.09)
2.13
0.02
0.02
N/A
N/A
N/A
(4.56)
0.07
1.44
Rate Of Daily Change
0.94
1.01
1.0
1.0
1.0
1.0
1.0
0.95
1.0
1.02
Day Median Price
1.45
154.26
11.28
12.89
33.78
1025.0
1.0E-4
85.85
31.87
68.88
Price Action Indicator
(0.09)
2.13
0.01
0.01
N/A
N/A
N/A
(4.00)
0.035
1.02
Relative Strength Index
45.7
64.18
66.74
64.82
59.37
N/A
N/A
48.78
44.1
68.01
Coefficient Of Variation
11762.14
1428.73
872.12
618.95
356.76
N/A
N/A
1679.86
(824.46)
1418.67
Mean Deviation
2.85
0.9381
0.6457
0.2643
0.5544
N/A
N/A
0.9868
0.4745
1.48
Jensen Alpha
(0.05)
0.0705
0.1475
0.0441
0.1811
N/A
N/A
0.0249
(0.09)
0.0926
Total Risk Alpha
(0.21)
0.0035
0.0725
0.0343
0.1447
N/A
N/A
(0.01)
(0.12)
0.0124
Sortino Ratio
(0)
0.0258
0.1579
0.0433
0.2203
N/A
N/A
0.0208
N/A
0.0378
Downside Variance
15.95
1.35
0.5363
0.1441
0.4189
N/A
N/A
2.19
N/A
4.41
Standard Deviation
3.91
1.19
1.47
0.4299
0.6977
N/A
N/A
1.41
0.5936
1.88
Kurtosis
1.11
0.4613
43.95
15.49
(0.03)
N/A
N/A
3.66
(0.21)
0.3158
Potential Upside
6.94
1.84
0.9259
0.5728
1.27
N/A
N/A
2.1
0.759
3.23
Treynor Ratio
0.0137
1.25
0.6142
0.1663
1.77
N/A
N/A
0.0648
(0.46)
0.1769
Maximum Drawdown
18.77
5.66
12.28
3.3
3.1
N/A
N/A
7.41
2.68
7.25
Variance
15.32
1.41
2.16
0.1848
0.4868
N/A
N/A
1.98
0.3524
3.53
Market Risk Adjusted Performance
0.0237
1.26
0.6242
0.1763
1.78
N/A
N/A
0.0748
(0.45)
0.1869
Risk Adjusted Performance
0.0144
0.0552
0.0892
0.1115
0.2052
N/A
N/A
0.0485
(0.09)
0.0578
Skewness
(0.02)
(0.22)
6.02
2.64
(0.15)
N/A
N/A
(0.37)
(0.38)
(0.39)
Semi Deviation
3.64
1.07
0.4417
0.146
0.33
N/A
N/A
1.4
N/A
1.92
Information Ratio
(0.01)
0.0253
0.0786
0.0383
0.2043
N/A
N/A
0.0219
(0.21)
0.0423
Value At Risk
(6.00)
(1.55)
(1.09)
(0.49)
(1.10)
N/A
N/A
(1.71)
(1.23)
(2.45)
Expected Short fall
(3.28)
(1.05)
(0.81)
(0.33)
(0.68)
N/A
N/A
(1.01)
N/A
(1.41)
Downside Deviation
3.99
1.16
0.7324
0.3797
0.6472
N/A
N/A
1.48
N/A
2.1
Semi Variance
13.25
1.15
0.1951
0.0213
0.1089
N/A
N/A
1.96
N/A
3.69

Beauty Health Competition Performance Charts

Five steps to successful analysis of Beauty Health Competition

Beauty Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Beauty Health in relation to its competition. Beauty Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Beauty Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Beauty Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Beauty Health, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Beauty Health position

In addition to having Beauty Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cleaning Thematic Idea Now

Cleaning
Cleaning Theme
Compnanies producing and distributing cleaning products, supplies, and accessories. The Cleaning theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cleaning Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Beauty Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Beauty Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Beauty Health Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Beauty Health Co Stock:
How To Invest In Beauty
Details
Is Beauty Stock a good investment?
Details
What is Beauty Health's Net Worth?
Details
Largest Personal Care Products Companies
View
Largest Household & Personal Products Companies
View
Check out Beauty Health Correlation with its peers.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Will Personal Care Products sector continue expanding? Could Beauty diversify its offerings? Factors like these will boost the valuation of Beauty Health. If investors know Beauty will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Beauty Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.16)
Revenue Per Share
2.403
Quarterly Revenue Growth
(0.10)
Return On Assets
(0.03)
Return On Equity
(0.19)
Beauty Health's market price often diverges from its book value, the accounting figure shown on Beauty's balance sheet. Smart investors calculate Beauty Health's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Beauty Health's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Beauty Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beauty Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beauty Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY